等待開盤 09-24 09:30:00 美东时间
+1.560
+3.52%
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Northland Capital Markets analyst Gus Richard upgrades Veeco Instruments (NASDAQ:VECO) from Market Perform to Outperform and maintains the price target from $66 to $66.
09-21 19:58
Veeco Instruments (NASDAQ:VECO) has outperformed the market over the past 5 years by 6.01% on an annualized basis producing an average annual return of 17.32%. Currently, Veeco Instruments has a market capitalization of $2.92 billion. Buying $1000 In VECO: If an investor had bought $1000 of VECO sto...
08-22 05:30
Veeco Instruments (NASDAQ:VECO) has outperformed the market over the past 5 years by 8.9% on an annualized basis producing an average annual return of 20.61%. Currently, Veeco Instruments has a market capitalization of $3.27 billion. Buying $1000 In VECO: If an investor had bought $1000 of VECO stoc...
08-13 07:30
Veeco Instruments Inc. announced that its management will participate in several investor events in August and September 2026, including Needham’s Virtual Semiconductor & SemiCap Conference, Jefferies’ Semiconductor Conference in Chicago, Citi’s Global TMT Conference in New York, and StoneX’s TMT Conference in New York. Veeco is a leading manufacturer of semiconductor process equipment, offering technologies for advanced semiconductor fabrication...
08-12 12:02
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Veeco Instruments Inc. (NASDAQ: VECO) today announced that a global leader in optical and photonic technologies has selected its LUMINA®+ Metal Organic Chemical Vapor Deposition (MOCVD) system to fabricate indium phosphide (InP) lasers for innovative communication solutions in the datacom industry. ...
08-06 04:36
Veeco Instruments (NASDAQ:VECO) lowers FY2026 GAAP EPS guidance from $0.83-$1.17 to $0.78-$1.02 vs $0.99 analyst estimate..
08-06 04:14
Veeco Instruments (NASDAQ:VECO) lowers FY2026 Adj EPS guidance from $1.50-$1.85 to $1.36-$1.61 vs $1.63 analyst estimate. Raises FY2026 sales outlook from $740.000 million-$800.000 million to $780.000 million-$810.000 million vs $780.490 million estimate.
08-06 04:13
Synaptics Incorporated涨9.46%;Vera Therapeutics, Inc. Class A涨4.69%;Equinox Gold Corp.涨3.83%
06-26 09:01